A case of diabetes following tibolone therapy.
Konstantopoulos
K
K
Adamides
S
S
D045930:Anabolic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001786:Blood Glucose / Q000378:metabolism; D002979:Climacteric / Q000187:drug effects*; D003131:Combined Modality Therapy; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000139:chemically induced* / Q000628:therapy; D003927:Diet, Diabetic; D005260:Female; D005905:Glyburide / Q000008:administration & dosage; D006029:Glycosuria / Q000097:blood / Q000139:chemically induced; D006801:Humans; D008875:Middle Aged; D009652:Norpregnenes / Q000008:administration & dosage / Q000009:adverse effects*
D045930:Anabolic Agents; D001786:Blood Glucose; D009652:Norpregnenes; C027385:tibolone; D005905:Glyburide